Moderately bullish activity in Novo Nordisk (NVO), with shares down 43c near $56.03. Options volume relatively light with 30k contracts traded and calls leading puts for a put/call ratio of 0.39, compared to a typical level near 0.57. Implied volatility (IV30) is higher by 3.0 points near 40.19,and below the 52wk median, suggesting an expected daily move of $1.42. Put-call skew flattened, suggesting a modestly bullish tone.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Analyst Forecasts $25 Billion of Annual Sales for Eli Lilly’s (LLY) New Weight-Loss Pill
- Chinese companies supplying ingredients for weight loss drugs, Reuters reports
- Novo Nordisk Stock Jumps and Eli Lilly Falls on Positive Wegovy Data
- Novo says Wegovy cut risk of heart attack, death by 57% compared to tirzepatide
- Eli Lilly (LLY) Rival Novo Nordisk’s Stock Pops in Europe on Wegovy Data